Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03890900 · ClinicalTrials.gov registry record · Phase 1
T2DXcel Mobile Application
A Phase 1 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 55
- Enrollment target
NCT03890900 is a Phase 1 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 55 participants.
The verdict
NCT03890900, a Phase 1 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 55 participants
- Enrollment target
Study Summary
Given the need for personalizable and adaptive mobile applications for patients with type 2 diabetes, this proposal will develop, evaluate, and refine a patient-centered mobile application (T2DXcel), which will deliver tailored and algorithm-based diabetes education to improve process and diabetes-related outcomes.
Interventions
- OTHER T2DXcel mobile application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2022-07-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03890900
The ClinicalTrials.gov registry entry for NCT03890900 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which T2DXcel mobile application is the first listed.
NCT03890900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03890900 about?
NCT03890900 is a clinical study titled "T2DXcel Mobile Application". Given the need for personalizable and adaptive mobile applications for patients with type 2 diabetes, this proposal will develop, evaluate, and refine a patient-centered mobile application (T2DXcel), which will deliver tailored and algorithm-based diabetes education to improve process and diabetes-r...
What is the current status of trial NCT03890900?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 55 participants. The study started on 2020-03-01. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT03890900?
The interventions under investigation include: T2DXcel mobile application (OTHER).
Who is sponsoring clinical trial NCT03890900?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.